Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 20, 2021

SELL
$110.72 - $210.04 $6,089 - $11,552
-55 Closed
0 $0
Q4 2020

Mar 09, 2021

BUY
$79.67 - $173.23 $4,381 - $9,527
55 New
55 $8,000
Q3 2020

Nov 19, 2020

SELL
$78.5 - $100.64 $6,986 - $8,956
-89 Closed
0 $0
Q2 2020

Aug 19, 2020

BUY
$38.5 - $76.05 $3,426 - $6,768
89 New
89 $6,000

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.61B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Tru Independence LLC Portfolio

Follow Tru Independence LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tru Independence LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tru Independence LLC with notifications on news.